1
|
Sarbadhikary P, George BP, Abrahamse H. Potential Application of Photosensitizers With High-Z Elements for Synergic Cancer Therapy. Front Pharmacol 2022; 13:921729. [PMID: 35837287 PMCID: PMC9274123 DOI: 10.3389/fphar.2022.921729] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2022] [Accepted: 05/17/2022] [Indexed: 01/10/2023] Open
Abstract
The presence of heavy elements in photosensitizers (PS) strongly influences their electronic and photophysical properties, and hence, conjugation of PS with a suitable element is regarded as a potential strategy to improve their photodynamic properties. Moreover, PS conjugated to metal ion or metal complex and heavy atoms such as halogen have attracted considerable attention as promising agents for multimodal or synergistic cancer therapy. These tetrapyrrole compounds depending on the type and nature of the inorganic elements have been explored for photodynamic therapy (PDT), chemotherapy, X-ray photon activation therapy (PAT), and radiotherapy. Particularly, the combination of metal-based PS and X-ray irradiation has been investigated as a promising novel approach for treating deep-seated tumors, which in the case of PDT is a major limitation due to low light penetration in tissue. This review will summarize the present status of evidence on the effect of insertion of metal or halogen on the photophysical properties of PS and the effectiveness of various metal and halogenated PS investigated for PDT, chemotherapy, and PAT as mono and/or combination therapy.
Collapse
|
2
|
Abstract
AbstractSpatially fractionated radiation therapy (SFRT) challenges some of the classical dogmas in conventional radiotherapy. The highly modulated spatial dose distributions in SFRT have been shown to lead, both in early clinical trials and in small animal experiments, to a significant increase in normal tissue dose tolerances. Tumour control effectiveness is maintained or even enhanced in some configurations as compared with conventional radiotherapy. SFRT seems to activate distinct radiobiological mechanisms, which have been postulated to involve bystander effects, microvascular alterations and/or immunomodulation. Currently, it is unclear which is the dosimetric parameter which correlates the most with both tumour control and normal tissue sparing in SFRT. Additional biological experiments aiming at parametrizing the relationship between the irradiation parameters (beam width, spacing, peak-to-valley dose ratio, peak and valley doses) and the radiobiology are needed. A sound knowledge of the interrelation between the physical parameters in SFRT and the biological response would expand its clinical use, with a higher level of homogenisation in the realisation of clinical trials. This manuscript reviews the state of the art of this promising therapeutic modality, the current radiobiological knowledge and elaborates on future perspectives.
Collapse
|
4
|
Brombal L, Arfelli F, Delogu P, Donato S, Mettivier G, Michielsen K, Oliva P, Taibi A, Sechopoulos I, Longo R, Fedon C. Image quality comparison between a phase-contrast synchrotron radiation breast CT and a clinical breast CT: a phantom based study. Sci Rep 2019; 9:17778. [PMID: 31780707 PMCID: PMC6882794 DOI: 10.1038/s41598-019-54131-z] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2019] [Accepted: 11/04/2019] [Indexed: 11/13/2022] Open
Abstract
In this study we compared the image quality of a synchrotron radiation (SR) breast computed tomography (BCT) system with a clinical BCT in terms of contrast-to-noise ratio (CNR), signal-to-noise ratio (SNR), noise power spectrum (NPS), spatial resolution and detail visibility. A breast phantom consisting of several slabs of breast-adipose equivalent material with different embedded targets (i.e., masses, fibers and calcifications) was used. Phantom images were acquired using a dedicated BCT system installed at the Radboud University Medical Center (Nijmegen, The Netherlands) and the SR BCT system at the SYRMEP beamline of Elettra SR facility (Trieste, Italy) based on a photon-counting detector. Images with the SR setup were acquired mimicking the clinical BCT conditions (i.e., energy of 30 keV and radiation dose of 6.5 mGy). Images were reconstructed with an isotropic cubic voxel of 273 µm for the clinical BCT, while for the SR setup two phase-retrieval (PhR) kernels (referred to as “smooth” and “sharp”) were alternatively applied to each projection before tomographic reconstruction, with voxel size of 57 × 57 × 50 µm3. The CNR for the clinical BCT system can be up to 2-times higher than SR system, while the SNR can be 3-times lower than SR system, when the smooth PhR is used. The peak frequency of the NPS for the SR BCT is 2 to 4-times higher (0.9 mm−1 and 1.4 mm−1 with smooth and sharp PhR, respectively) than the clinical BCT (0.4 mm−1). The spatial resolution (MTF10%) was estimated to be 1.3 lp/mm for the clinical BCT, and 5.0 lp/mm and 6.7 lp/mm for the SR BCT with the smooth and sharp PhR, respectively. The smallest fiber visible in the SR BCT has a diameter of 0.15 mm, while for the clinical BCT is 0.41 mm. Calcification clusters with diameter of 0.13 mm are visible in the SR BCT, while the smallest diameter for the clinical BCT is 0.29 mm. As expected, the image quality of the SR BCT outperforms the clinical BCT system, providing images with higher spatial resolution and SNR, and with finer granularity. Nevertheless, this study assesses the image quality gap quantitatively, giving indications on the benefits associated with SR BCT and providing a benchmarking basis for its clinical implementation. In addition, SR-based studies can provide a gold-standard in terms of achievable image quality, constituting an upper-limit to the potential clinical development of a given technique.
Collapse
Affiliation(s)
- Luca Brombal
- Department of Physics, University of Trieste, 34127, Trieste, Italy.,INFN Division of Trieste, 34127, Trieste, Italy
| | - Fulvia Arfelli
- Department of Physics, University of Trieste, 34127, Trieste, Italy.,INFN Division of Trieste, 34127, Trieste, Italy
| | - Pasquale Delogu
- Department of Physical Sciences, Earth and Environment, University of Siena, 53100, Siena, Italy.,INFN Division of Pisa, 56127, Pisa, Italy
| | - Sandro Donato
- Department of Physics, University of Trieste, 34127, Trieste, Italy.,INFN Division of Trieste, 34127, Trieste, Italy
| | - Giovanni Mettivier
- Department of Physics, University of Napoli Federico II, 80126, Fuorigrotta Napoli, Italy.,INFN Division of Napoli, 80126, Fuorigrotta Napoli, Italy
| | - Koen Michielsen
- Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands
| | - Piernicola Oliva
- Department of Chemistry and Pharmacy, University of Sassari, 07100, Sassari, Italy.,INFN Division of Cagliari, 09042, Monserrato Cagliari, Italy
| | - Angelo Taibi
- Department of Physics and Earth Science, University of Ferrara, 44122, Ferrara, Italy.,INFN Division of Ferrara, 44122, Ferrara, Italy
| | - Ioannis Sechopoulos
- Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.,Dutch Expert Center for Screening (LRCB), 6503 GJ, Nijmegen, The Netherlands
| | - Renata Longo
- Department of Physics, University of Trieste, 34127, Trieste, Italy. .,INFN Division of Trieste, 34127, Trieste, Italy.
| | - Christian Fedon
- INFN Division of Trieste, 34127, Trieste, Italy.,Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands
| |
Collapse
|
5
|
Fedon C, Caballo M, Longo R, Trianni A, Sechopoulos I. Internal breast dosimetry in mammography: Experimental methods and Monte Carlo validation with a monoenergetic x-ray beam. Med Phys 2018; 45:1724-1737. [DOI: 10.1002/mp.12792] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2017] [Revised: 12/05/2017] [Accepted: 01/19/2018] [Indexed: 11/12/2022] Open
Affiliation(s)
- Christian Fedon
- Department of Radiology and Nuclear Medicine; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen The Netherlands
- Istituto Nazionale di Fisica Nucleare (INFN); sezione di Trieste; 34127 Trieste Italy
| | - Marco Caballo
- Department of Radiology and Nuclear Medicine; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen The Netherlands
| | - Renata Longo
- Istituto Nazionale di Fisica Nucleare (INFN); sezione di Trieste; 34127 Trieste Italy
- Dipartimento di Fisica; Università degli Studi di Trieste; 34127 Trieste Italy
| | - Annalisa Trianni
- Medical Physics Department; Azienda Sanitaria Universitaria Integrata (ASUIUD) - Presidio Ospedaliero “S. Maria della Misericordia”; p.le S. Maria della Misericordia, 15 33100 Udine Italy
| | - Ioannis Sechopoulos
- Department of Radiology and Nuclear Medicine; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen The Netherlands
- Dutch Expert Center for Screening (LRCB); PO Box 6873 6503 GJ Nijmegen The Netherlands
| |
Collapse
|
6
|
Sarbadhikary P, Dube A. Enhancement of radiosensitivity of oral carcinoma cells by iodinated chlorin p 6 copper complex in combination with synchrotron X-ray radiation. JOURNAL OF SYNCHROTRON RADIATION 2017; 24:1265-1275. [PMID: 29091070 DOI: 10.1107/s1600577517012711] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2017] [Accepted: 09/05/2017] [Indexed: 06/07/2023]
Abstract
The combination of synchrotron X-ray radiation and metal-based radiosensitizer is a novel form of photon activation therapy which offers the advantage of treating malignant tumors with greater efficacy and higher precision than conventional radiation therapy. In this study the anticancer cytotoxic efficacy of a new chlorophyll derivative, iodinated chlorin p6 copper complex (ICp6-Cu), combined with synchrotron X-ray radiation (8-10 keV) in two human oral cancer cell lines is explored. Pre-treatment of cells with 20 µM and 30 µM ICp6-Cu for 3 h was found to enhance the X-ray-induced cytotoxicity with sensitization enhancement ratios of 1.8 and 2.8, respectively. ICp6-Cu localized in cytoplasm, mainly in lysosomes and endoplasmic reticulum, and did not cause any cytotoxicity alone. The radiosensitization effect of ICp6-Cu accompanied a significant increase in the level of reactive oxygen species, damage to lysosomes, inhibition of repair of radiation-induced DNA double-strand breaks, increase in cell death and no significant effect on cell cycle progression. These results demonstrate that ICp6-Cu is a potential agent for synchrotron photon activation therapy of cancer.
Collapse
Affiliation(s)
- Paromita Sarbadhikary
- Laser Biomedical Applications Section, Raja Rammana Centre for Advanced Technology, Indore, Madhya Pradesh 452013, India
| | - Alok Dube
- Laser Biomedical Applications Section, Raja Rammana Centre for Advanced Technology, Indore, Madhya Pradesh 452013, India
| |
Collapse
|